ClinConnect ClinConnect Logo
Search / Trial NCT06298513

Autonomic and Metabolic Response to Cardiac Rehabilitation After Acute MI

Launched by ISTITUTO AUXOLOGICO ITALIANO · Mar 1, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

Myocardial Infarction Cardiac Rehabilitation Metabolomic Autonomic Nervous Ststem

ClinConnect Summary

This clinical trial is studying how cardiac rehabilitation—an organized program of exercise and education—can change the body’s metabolism after a first heart attack (also called an acute myocardial infarction). Researchers want to understand if participating in this rehabilitation program can improve the way the body processes nutrients and energy, and whether these changes can affect common risk factors for heart disease, like blood sugar and cholesterol levels.

To be eligible for this study, participants need to be men who have recently experienced their first heart attack, but those with severe diabetes cannot participate. If you or someone you know meets these criteria and decides to join, they can expect to take part in rehabilitation sessions designed to help recover from the heart attack while also contributing to important research that could benefit future heart patients. This study is currently recruiting participants, so now is a great time to get involved!

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • recent first acute myocardial infarction
  • Exclusion Criteria:
  • severe diabetes

About Istituto Auxologico Italiano

Istituto Auxologico Italiano is a prominent Italian research institute dedicated to advancing medical science and improving patient care through innovative clinical research. With a strong focus on metabolic diseases, cardiovascular health, and neuropsychological disorders, the institute integrates clinical practice with cutting-edge research to foster the development of new therapeutic strategies. Committed to ethical standards and patient safety, Istituto Auxologico Italiano collaborates with various national and international partners, contributing significantly to the global medical community while ensuring high-quality care and support for its patients.

Locations

Milan, , Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported